# Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM

> **NCT00508456** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 18 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** Temodar (Temozolomide)
- **DIETARY_SUPPLEMENT:** Hominex-2

## Key facts

- **NCT ID:** NCT00508456
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-08
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2012-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00508456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00508456, "Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00508456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*